Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients
dc.contributor.buuauthor | Çelebi, Solmaz | |
dc.contributor.buuauthor | Hacımustafaoğlu, Mustafa Kemal | |
dc.contributor.buuauthor | Köksal, Nilgün | |
dc.contributor.buuauthor | Özkan, Hilal | |
dc.contributor.buuauthor | Çetinkaya, Merih | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.researcherid | AAG-8393-2021 | tr_TR |
dc.contributor.scopusid | 7006095295 | tr_TR |
dc.contributor.scopusid | 6602154166 | tr_TR |
dc.contributor.scopusid | 7003323615 | tr_TR |
dc.contributor.scopusid | 16679325400 | tr_TR |
dc.contributor.scopusid | 23994946300 | tr_TR |
dc.date.accessioned | 2021-12-20T06:39:12Z | |
dc.date.available | 2021-12-20T06:39:12Z | |
dc.date.issued | 2010-06 | |
dc.description.abstract | Aim: The aim of the present study was to assess the efficacy and safety of colistimethate sodium therapy in multidrug-resistant nosocomial infections caused by Pseudomonas aeruginosa or Acinetobacter baumannii in neonates and children. Methods: Pediatric patients hospitalized at the Uludag University Hospital who had nosocomial infections caused by multidrug-resistant P. aeruginosa or A. baumannii, were enrolled in the study. Colistimethate sodium at a dosage of 50-75 x 103 U/kg per day was given i.v. divided into three doses. Results: Fifteen patients received 17 courses of colistimethate sodium for the following infections: ventilator-associated pneumonia (n = 14), catheter-related sepsis (n = 1) and skin and soft-tissue infection (n = 2). The mean age of patients was 53.2 + 74.7 months (range, 8 days-15 years) and 60% were male. Mortality was 26.6%. Conclusion: Colistimethate sodium appears to be safe and effective for the treatment of severe infections caused by multidrug-resistant P. aeruginosa or A. baumannii in pediatric patients. | en_US |
dc.identifier.citation | Çelebi, S. vd. (2010). "Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients". Pediatrics International, 52(3), 410-414. | en_US |
dc.identifier.endpage | 414 | tr_TR |
dc.identifier.issn | 1328-8067 | |
dc.identifier.issn | 1442-200X | |
dc.identifier.issue | 3 | tr_TR |
dc.identifier.pubmed | 20003141 | tr_TR |
dc.identifier.scopus | 2-s2.0-77953635339 | tr_TR |
dc.identifier.startpage | 410 | tr_TR |
dc.identifier.uri | https://doi.org/10.1111/j.1442-200X.2009.03015.x | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/j.1442-200X.2009.03015.x | |
dc.identifier.uri | http://hdl.handle.net/11452/23381 | |
dc.identifier.volume | 52 | tr_TR |
dc.identifier.wos | 000278803000029 | |
dc.indexed.pubmed | Pubmed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.journal | Pediatrics International | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acinetobacter baumannii | en_US |
dc.subject | Children | en_US |
dc.subject | Colistimethate sodium | en_US |
dc.subject | Nosocomial infection | en_US |
dc.subject | Pseudomonas aeruginosa | en_US |
dc.subject | Ventilator-associated pneumonia | en_US |
dc.subject | Intensive-care-unit | en_US |
dc.subject | Pseudomonas-aeruginosa | en_US |
dc.subject | Intravenous colistin | en_US |
dc.subject | Nosocomial infections | en_US |
dc.subject | Risk-factors | en_US |
dc.subject | Acinetobacter | en_US |
dc.subject | Pediatrics | en_US |
dc.subject.emtree | Colistimethate | en_US |
dc.subject.emtree | Colistin | en_US |
dc.subject.emtree | Acinetobacter baumannii | en_US |
dc.subject.emtree | Acute kidney failure | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bacterium detection | en_US |
dc.subject.emtree | Catheter infection | en_US |
dc.subject.emtree | Child | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Creatinine blood level | en_US |
dc.subject.emtree | Creatinine clearance | en_US |
dc.subject.emtree | Drug efficacy | en_US |
dc.subject.emtree | Drug safety | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Hospital infection | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Infant | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Nephrotoxicity | en_US |
dc.subject.emtree | Neuromuscular blocking | en_US |
dc.subject.emtree | Newborn | en_US |
dc.subject.emtree | Pediatrics | en_US |
dc.subject.emtree | Preschool child | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Pseudomonas aeruginosa | en_US |
dc.subject.emtree | School child | en_US |
dc.subject.emtree | Sepsis | en_US |
dc.subject.emtree | Side effect | en_US |
dc.subject.emtree | Skin infection | en_US |
dc.subject.emtree | Soft tissue infection | en_US |
dc.subject.emtree | Treatment duration | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Treatment response | en_US |
dc.subject.emtree | University hospital | en_US |
dc.subject.emtree | Ventilator associated pneumonia | en_US |
dc.subject.mesh | Acinetobacter baumannii | en_US |
dc.subject.mesh | Acinetobacter infections | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, preschool | en_US |
dc.subject.mesh | Colistin | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Dose-response relationship, drug | en_US |
dc.subject.mesh | Drug administration schedule | en_US |
dc.subject.mesh | Drug resistance, multiple, bacterial | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Follow-up studies | en_US |
dc.subject.mesh | Hospitals, university | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Infant, newborn | en_US |
dc.subject.mesh | Injections, intravenous | en_US |
dc.subject.mesh | Intensive care units, neonatal | en_US |
dc.subject.mesh | Intensive care units, pediatric | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Microbial sensitivity tests | en_US |
dc.subject.mesh | Prospective studies | en_US |
dc.subject.mesh | Pseudomonas aeruginosa | en_US |
dc.subject.mesh | Pseudomonas infections | en_US |
dc.subject.mesh | Statistics, nonparametric | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.scopus | Colistin; Polymyxins; Ventilator Associated Pneumonia | en_US |
dc.subject.wos | Pediatrics | en_US |
dc.title | Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients | en_US |
dc.type | Article | |
dc.wos.quartile | Q4 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: